Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Eur J Radiol. 2009 Mar 4;70(2):265–273. doi: 10.1016/j.ejrad.2009.01.043

Figure 1.

Figure 1

Schematic representation of reporter-PNA-ligand probe wherein reporter can be radioisotope like 64Cu or 99mTc, or contrast agent like Gd for MRI, bound to macrocyclic chelator DOTA, PNA sequence complementary to oncogene mRNA, and peptide ligand specific for overexpressed receptors on cancer cells.